EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling

被引：14

作者：

Yue, Xuetian ^{[1
]}

Wu, Fangnan ^{[1
]}

Wang, Jianming ^{[1
]}

Kim, Kaitlin ^{[1
]}

Santhamma, Bindu ^{[2
]}

Dileep, Kalarickal V. ^{[3
]}

Zhang, Kam Y. J. ^{[3
]}

Viswanadhapalli, Suryavathi ^{[4
]}

Vadlamudi, Ratna K. ^{[4
]}

Ahmed, Gulzar ^{[2
]}

Feng, Zhaohui ^{[1
]}

Nickisch, Klaus ^{[2
]}

Hu, Wenwei ^{[1
]}

机构：

[1] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA

[2] Evestra Inc, San Antonio, TX 78245 USA

[3] RIKEN, Ctr Biosyst Dynam Res, Lab Struct Bioinformat, Yokohama, Kanagawa 2300045, Japan

[4] Univ Texas Hlth San Antonio, Dept Obstertr & Gynecol, San Antonio, TX 78229 USA

来源：

JOURNAL OF MOLECULAR CELL BIOLOGY | 2020年 / 12卷 / 06期

基金：

日本学术振兴会; 美国国家卫生研究院;

关键词：

PANCREATIC-CANCER; ACTIVATION;

D O I：

10.1093/jmcb/mjaa008

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：477 / 480

页数：4

共 18 条

[1] Examination of pathways involved in leukemia inhibitory factor (LIF)-induced cell growth arrest using label-free proteomics approach [J].

Ali, Syed Azmal ;

Kaur, Gurjeet ;

Kaushik, Jai Kumar ;

Malakar, Dhruba ;

Mohanty, Ashok Kumar ;

Kumar, Sudarshan .

JOURNAL OF PROTEOMICS, 2017, 168 :37-52

[2] LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker [J].

Bressy, Christian ;

Lac, Sophie ;

Nigri, Jeremy ;

Leca, Julie ;

Roques, Julie ;

Lavaut, Marie-Noelle ;

Secq, Veronique ;

Guillaumond, Fabienne ;

Bui, Thi-Thien ;

Pietrasz, Daniel ;

Granjeaud, Samuel ;

Bachet, Jean-Baptiste ;

Ouaissi, Mehdi ;

Iovanna, Juan ;

Vasseur, Sophie ;

Tomasini, Richard .

CANCER RESEARCH, 2018, 78 (04) :909-921

[3] A Unique Loop Structure in Oncostatin M Determines Binding Affinity toward Oncostatin M Receptor and Leukemia Inhibitory Factor Receptor [J].

Chollangi, Srinivas ;

Mather, Timothy ;

Rodgers, Karla K. ;

Ash, John D. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (39) :32848-32859

[4] The Role of the Leukemia Inhibitory Factor (LIF) - Pathway in Derivation and Maintenance of Murine Pluripotent Stem Cells [J].

Graf, Urs ;

Casanova, Elisa A. ;

Cinelli, Paolo .

GENES, 2011, 2 (01) :280-297

[5] Principles of interleukin (IL)-6-type cytokine signalling and its regulation [J].

Heinrich, PC ;

Behrmann, I ;

Haan, S ;

Hermanns, HM ;

Müller-Newen, G ;

Schaper, F .

BIOCHEMICAL JOURNAL, 2003, 374 (01) :1-20

[6] Comparing antibody and small-molecule therapies for cancer [J].

Imai, Kohzoh ;

Takaoka, Akinori .

NATURE REVIEWS CANCER, 2006, 6 (09) :714-727

[7] Leukemia inhibitory factor regulates marmoset induced pluripotent stem cell proliferation via a PI3K/Akt-dependent Tbx-3 activation pathway [J].

Ke, Minxia ;

He, Quan ;

Hong, Danping ;

Li, Ouyang ;

Zhu, Mengyi ;

Ou, Wen-Bin ;

He, Yulong ;

Wu, Yuehong .

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (01) :131-140

[8] LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway [J].

Li, Xiaoyan ;

Yang, Qifeng ;

Yu, Haiyang ;

Wu, Lihua ;

Zhao, Yuhan ;

Zhang, Cen ;

Yue, Xuetian ;

Liu, Zhen ;

Wu, Hao ;

Haffty, Bruce G. ;

Feng, Zhaohui ;

Hu, Wenwei .

ONCOTARGET, 2014, 5 (03) :788-801

[9] Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance [J].

Liu, Shu-Chen ;

Tsang, Ngan-Ming ;

Chiang, Wen-Che ;

Chang, Kai-Ping ;

Hsueh, Chuen ;

Liang, Ying ;

Juang, Jyh-Lyh ;

Chow, Kai-Ping N. ;

Chang, Yu-Sun .

JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (12) :5269-5283

[10]

Nair H., 2018, US patent, Patent No. [10,053,485, 10053485]

← 1 2 →